The United States is launching a sweeping effort to revitalize its domestic defense industry and secure its energy independence through a series of aggressive new initiatives. In a coordinated push to reduce reliance on foreign
The US Department of the Treasury has sparked a heated debate among economists and investors by announcing plans to roughly double the size of its long dated bond buyback operations. Starting in early September, the
A wave of anxiety over potential U.S. trade policies has triggered a massive scramble among traders to flood American warehouses with refined copper. Fearing that new import tariffs could soon make shipments prohibitively expensive, market
Washington is currently pouring billions of dollars into a massive overhaul of its domestic resource landscape, treating the procurement of critical minerals and AI infrastructure as a matter of urgent national security. Since early 2025,
Agnico Eagle Mines is expanding its footprint in Quebec with a strategic investment of 57.1 million Canadian dollars, roughly 41.1 million US dollars, to take a significant stake in Radisson Mining Resources. Through a non
United States Antimony has significantly ramped up its efforts in Montana, announcing that it has more than doubled the daily extraction rate at its Stibnite Hill mine. The company is now pulling 42 tons of
A promising diplomatic thaw between Ottawa and Washington turned ice cold this week as trade negotiations abruptly collapsed on August 21. Despite earlier signs of progress and a brief extension of deadlines by President Donald
The cryptocurrency market experienced a dramatic resurgence on Friday morning, sending Bitcoin soaring to nearly 78,000 dollars. This rally marks one of the asset's strongest weekly performances since early 2024, with the leading digital currency
The landscape of oncology is currently undergoing a massive transformation as pharmaceutical giants race to develop best-in-class therapeutics for some of the world's deadliest diseases. Because cancer remains the second leading cause of death globally,
Investors poured into Moderna and Merck on Wednesday after the two pharmaceutical giants announced a major victory in their fight against skin cancer. A late stage clinical trial revealed that a personalized mRNA vaccine called
